Afatinib Market Trend

Afatinib Market Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC). Afatinib is a targeted therapy. Afatinib is classified as a Tyrosine Kinase…